chronic-kidney-disease

Documents about chronic-kidney-disease

• A Study to Learn How Safe BAY3283142 is When Taken as a Single Dose or as Multiple Doses in Healthy Chinese Participants#855364ClinicalTrials.gov
• Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone#879419ClinicalTrials.gov
• Mitochondria-related pathogenic genes in acute and chronic kidney disease: a Mendelian randomization study#350246Figshare
• Effect of Dry-weight Probing Guided by Lung-Ultrasound on Ambulatory Blood Pressure and Arterial Stiffness in Hemodialysis Patients (LUST Sub-Study)#827238ClinicalTrials.gov
• A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function#879230ClinicalTrials.gov
• A Multi-Centered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 (Zuragen) Solution, and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis#888541ClinicalTrials.gov
• Can Changes in Dialysate Sodium Concentration Improve Blood Pressure and Endothelial Function in Chronic HD Patients?#829082ClinicalTrials.gov
• Impact Of Statin And Identification Of Risk Factors Associated With The Development Of Chronic Kidney Disease In Type 2 Diabetic Patients: A Retrospective Cohort Study In The United Arab Emirates#270896USM Repository
• Precision T1D Platform - New Therapies for Cardio-Renal Complications#871060ClinicalTrials.gov
• An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions#896333ClinicalTrials.gov
• SGLT-2 Inhibitors on Albuminuria in Chronic Kidney Disease Patients With Lupus Nephritis and ANCA- Associated Vasculitis#896487ClinicalTrials.gov
• Pharmacokinetic/Pharmacodynamic Parameters of NNG-DEPO (Stimus) With Aranesp® (Amgen) in Treatment of Anemia in CKD Patients on Dialysis#911128ClinicalTrials.gov
• This Study is to Estimate the Efficacy of Hemodialysis Alone for Uric Acid Clearance in Patients on Hemodialysis. In Order to Evaluate the Need of Adjuvant Uric Acid Lowering Therapy#980288ClinicalTrials.gov
• Chronic Kidney Disease (CKD): Systematic Review of the Cost Effectiveness of SGLT2 Inhibitors and Other Novel Nephroprotective Drugs#203576Springer Nature OA
• Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria#803436ClinicalTrials.gov
• Safety and Efficacy of Sofosbuvir Based Antiviral Regimen for Treating Hepatitis C in Patients With Moderate to Advanced Chronic Kidney Disease and Patients Receiving Renal Replacement Therapy#869117ClinicalTrials.gov
• Non-surgical Periodontal Therapy and Kidney Outcomes in Type 2 Diabetes Mellitus#968220ClinicalTrials.gov
• Albumin as a dynamic extracellular redox regulator: from Cys34 oxidation biomarkers to polysulfide-mediated homeostatic mechanisms and clinical applications#257157Europe PMC
• Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i as Triple Therapy With Type 2 Diabetes and Chronic Kidney Disease#329471ClinicalTrials.gov
• Defining the Roles of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Management of Chronic Kidney Disease in Adults with Type 2 Diabetes With or Without Overweight/Obesity: An International Delphi Consensus.#483469NCBI PubMed Central
• Differentiation between emerging non-steroidal and established steroidal mineralocorticoid receptor antagonists: head-to-head comparisons of pharmacological and clinical characteristics#677152HAL (France)
• Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study#6812OpenAlex
• Cancer and Blood Pressure Management, CARISMA Study#201644ClinicalTrials.gov
• Vitamin D status and intermediate vascular and bone outcomes in chronic kidney disease: a secondary post hoc analysis of IMPROVE-CKD#393455ResearchOnline@ND
• The safety window of blood magnesium in pulmonary complications of non-pulmonary sepsis: A U-shaped risk and prognostic analysis based on MIMIC-IV#281564PLOS
• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk#373736ClinicalTrials.gov
• Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis#804581ClinicalTrials.gov
• Roxadustat for Bone and Neuropsychiatric Aspects in Hemodialysis Patients#867771ClinicalTrials.gov
• A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin#858643ClinicalTrials.gov
• Sodium Zirconium Cyclosilicate to Allow Liberal Fruit and Vegetable Intake for Patients With CKD Stage 3b and 4#894505ClinicalTrials.gov
• Extreme Heat Exposure and All-Cause Mortality in Chronic Kidney Disease: A Nationwide Time-Stratified Case-Crossover Study of More Than One Million Patients#448621Figshare
• Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and Nephropathy#861383ClinicalTrials.gov
• The effectiveness of chronic kidney disease education towards knowledge, attitude, practice and HBA1C amongst uncontrolled type 2 diabetic patients in Hospital Universiti Sains Malaysia#190823USM Repository
• A Study Using Surveys to Learn More About Treatment With Steroidal Mineralocorticoid Receptor Antagonists, How They Are Used, What Side Effects They Have, and How Satisfied People Who Receive Them Are in the US#827561ClinicalTrials.gov
• Effect of Low Doses of Hypoxia-inducible Factor- Prolyl Hydroxylase Enzyme Inhibitor Plus Iron in the Treatment of Anemia in Dialysis-dependent Chronic Kidney Disease Patients#912610ClinicalTrials.gov
• Cohort Study on Patient Outcomes, Effectiveness and Cost-effectiveness of Intervention Programmes for DM/HT Patients#966263ClinicalTrials.gov
• A dual role of AcSDKP in chronic kidney disease: Targeting pericyte-driven fibrosis and vascular repair via <i>VEGF/FGFR1</i> while eliciting a compensatory <i>FGFR1</i> upregulation in apoptotic tubular cells#686601PLOS
• A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy#811942ClinicalTrials.gov
• Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)#875264ClinicalTrials.gov
• Study on the Safety of the Drug Runcaciguat and How Well it Works When Given at the Highest Dose as Tolerated by Individual Patient Whose Kidneys Are Not Working Properly and Suffering at the Same Time From High Blood Sugar and/or High Blood Pressure and a Disease of the Heart and the Blood Vessels.#460003ClinicalTrials.gov
• The association between atherogenic index of plasma, cumulative atherogenic index of plasma and type 2 diabetes mellitus with chronic kidney disease among older Chinese adults: Findings from the CHARLS study#437351PLOS
• Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary Hyperparathyroidism#913529ClinicalTrials.gov
• A Study to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body, How it Moves Into, Through and Out of the Body When Single and Multiple Amounts Are Taken as Tablets in Japanese Healthy Male Participants#858033ClinicalTrials.gov
• Investigation of the Effects of Medium Cut-off Dialyzers Versus High-Flux Dialyzers on Clinical and Laboratory Parameters of Prevalent Hemodialysis Patients#870326ClinicalTrials.gov
• Urinary Function and Multimorbidity Risks: A Longitudinal Study in Beijing Community-Dwelling Elderly#885336ClinicalTrials.gov
• Oral health in early and advanced stages (1-4) of chronic kidney disease: A systematic review and meta-analysis / Christian Niederau, Asia Azad Ali, Saida Chahboun, Sahir Kalim, Mariano Rodriguez Portillo, Rafael Kramann, Ulrike Schulze-Späte, Stefan Wolfart, Joachim Jankowski, Michael Wolf, Rogerio B. Craveiro#780412Deutsche Nationalbibliothek
• Effect of Vitamin D Supplementation on Coronary Calcification and Parathyroid Hormone in CKD Patients#849636ClinicalTrials.gov
• <b>Dietary Patterns and Physical Activity in Relation to Renal and Metabolic Outcomes among Older Adults with Type 2 Diabetes and Chronic Kidney Disease: A Systematic Review</b>#380004Figshare
• Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor#982373ClinicalTrials.gov
• Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant#804661ClinicalTrials.gov